[Featured Stock] Samsung Bio, Rises Over 4%... Climbs to 3rd in Market Cap

Samsung Biologics surged over 4%, climbing to the 3rd position in market capitalization on the KOSPI.

As of 10:07 AM on the 7th, Samsung Biologics' stock price was trading at 1,136,000 KRW per share, up 4.22% from the previous close. During the session, it briefly hit 1,140,000 KRW, setting a new 52-week high.

Accordingly, Samsung Biologics' market capitalization increased from 67.5 trillion KRW at the end of last year to approximately 80.78 trillion KRW currently. Based on KOSPI market capitalization, it surpassed LG Energy Solution to take the 3rd spot. Meanwhile, LG Energy Solution, now ranked 4th, is experiencing a decline of over 1%.

Samsung Biologics is expected to continue its earnings growth as its 4th plant begins full operation this year. Following record-high earnings last year, growing expectations for this year's performance are driving the stock price upward.

Earlier, securities firms including KB Securities raised their target prices based on these optimistic expectations. Kiwoom Securities projected Samsung Biologics' sales this year at 5.7 trillion KRW, exceeding the company's guidance.

This content was produced with the assistance of AI translation services.